Pharmaceuticals Analysts, along with Dr. Liangpunsakul of Roudebush VAMC and Indiana University, discuss DURECT’s Larsucosterol’s Potential in Alcohol-Associated Hepatitis (AH) ahead of potentially Pivotal Phase 2b readout in the 4Q2023 on an Analyst/Industry conference call to be held on October 16 at 12 pm.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DRRX:
